AbbVie (ABBV) beats sales and earnings expectations
Dividend Aristocrat AbbVie (ABBV) reported fourth-quarter earnings on Friday that were above consensus and the company raised its guidance for 2020. The company beats sales and earings expectations with 5.3% operational revenue growth and 16.3% growth in adjusted earnings-per-share. AbbVie AbbVie is also raising its 2020 EPS guidance of $7.66 to $7.76, representing growth of…